Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients

被引：50

作者：

Regent, Alexis ^{[1
]}

Redeker, Serge ^{[2
]}

Deroux, Alban ^{[3
]}

Kieffer, Pierre ^{[4
]}

Ly, Kim Heang ^{[5
]}

Dougados, Maxime ^{[6
]}

Liozon, Eric ^{[5
]}

Larroche, Claire ^{[7
]}

Guillevin, Loic ^{[1
]}

Bouillet, Laurence ^{[3
]}

Espitia, Olivier ^{[8
]}

Costedoat-Chalumeau, Nathalie ^{[1
]}

Soubrier, Martin ^{[9
]}

Brihaye, Benoit ^{[10
]}

Lifermann, Francois ^{[11
]}

Lefevre, Guillaume ^{[12
]}

Puechal, Xavier ^{[13
,14
]}

Mouthon, Luc ^{[13
,14
]}

Toussirot, Eric ^{[15
]}

机构：

[1] Univ Paris 05, Hop Cochin, APHP, Ctr Reference Malad Autoimmunes & Syst Rares,Serv, Paris, France

[2] Ctr Hosp Abbeville, Serv Med Interne, Abbeville, France

[3] Univ Grenoble Alpes, Serv Med Interne, CHU Grenoble, Grenoble, France

[4] Ctr Hosp Gen Mulhouse, Serv Med Interne, Mulhouse, France

[5] CHU Limoges, Serv Med Interne, Limoges, France

[6] Univ Paris 05, Hop Cochin, APHP,INSERM,PRES Sorbonne Paris Cite, Clin Epidemiol & Biostat,Dept Rheumatol,U1153, Paris, France

[7] Hop Avicenne, Serv Med Interne, Avicenne, France

[8] Hop Hotel Dieu, Serv Med Interne, Paris, France

[9] CHU Clermont Ferrand, Serv Rhumatol, Clermont Ferrand, France

[10] Hop St Quentin, Serv Med Interne & Med Polyvalente, Paris, France

[11] CH Dax, Serv Med Interne, Dax, France

[12] Hop Claude Huriez, Serv Med Interne, Paris, France

[13] Univ Paris 05, Paris, France

[14] Hop Cochin, APHP, Serv Med Interne, Ctr Reference Malad Autoimmunes & Syst Rares, Paris, France

[15] CHRU, INSERM CIC 1431, FHU INCREASE,Serv Rhumatol, Ctr Invest Clin Biotherapie, Paris, France

来源：

JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 08期

关键词：

GIANT CELL ARTERITIS; TOCILIZUMAB; BIOLOGICAL THERAPY; LARGE-VESSEL VASCULITIS; INTERLEUKIN-6;

D O I：

10.3899/jrheum.151252

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To report the efficacy and safety of tocilizumab (TCZ) for giant cell arteritis (GCA). Methods. A retrospective multicenter study that included 34 patients receiving TCZ for GCA. Results. TCZ was effective in all but 6 patients, who still had mild symptoms. Mean glucocorticoid dose was tapered. One patient died and 3 patients had to stop TCZ therapy because of severe adverse events. Twenty-three patients stopped treatment; 8 of these experienced relapses after a mean of 3.5 +/- 1.3 months. Conclusion. TCZ is effective in GCA. However, side effects occur. Whether this treatment has only a suspensive effect remains to be determined.

引用

页码：1547 / 1552

页数：6

共 50 条

[1] Tocilizumab for Giant Cell Arteritis in Japan over 2 Years: A Multicenter Retrospective Study
Oda, Nobuhiro
Fukui, Sho
Yamaguchi, Toshihiro
Nagase, Fumika
Ito, Takanori
Watanabe, Mitsuru
Haji, Yoichiro
Suyama, Yasuhiro
Nomura, Atsushi
Uechi, Eishi
Suda, Masei
Takizawa, Naoho
Rokutanda, Ryo
Tamaki, Hiromichi
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3328 - 3330
[2] Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Loricera, Javier
Castaneda, Santos
Moriano, Clara
Narvaez, Javier
Aldasoro, Vicente
Maiz, Olga
Melero, Rafael
Villa, Ignacio
Vela, Paloma
Romero-Yuste, Susana
Callejas, Jose L.
de Miguel, Eugenio
Galindez-Agirregoikoa, Eva
Sivera, Francisca
Fernandez-Lopez, Jesus C.
Galisteo, Carles
Ferraz-Amaro, Ivan
Sanchez-Martin, Julio
Sanchez-Bilbao, Lara
Calderon-Goercke, Monica
Casado, Alfonso
Hernandez, Jose L.
Gonzalez-Gay, Miguel A.
Blanco, Ricardo
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
[3] Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice
Martin-Gutierrez, Adrian
Loricera, Javier
Aldasoro, Vicente
Maiz, Olga
de Miguel, Eugenio
Galindez-Agirregoikoa, Eva
Ferraz-Amaro, Ivan
Castaneda, Santos
Blanco, Ricardo
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 71
[4] TREATMENT OF GIANT CELL ARTERITIS WITH TOCILIZUMAB: A RETROSPECTIVE COHORT STUDY OF 119 PATIENTS
Rakholiya, J.
Koster, M.
Langenfeld, H.
Crowson, C. S.
Abril, A.
Bansal, P.
Mertz, L.
Rodriguez-Pla, A.
Sehgal, R.
Wang, B.
Warrington, K. J.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 655 - 655
[5] Treatment of Giant Cell Arteritis with Tocilizumab: A Retrospective Cohort Study of 119 Patients
Rakholiya, Jigisha
Koster, Matthew
Langenfeld, Hannah
Crowson, Cynthia
Abril, Andy
Bansal, Pankaj
Mertz, Lester
Pla, Alicia Rodriguez
Sehgal, Rahul
Wang, Benjamin
Warrington, Kenneth
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2923 - 2925
[6] Tocilizumab in giant cell arteritis: a multicentre open-label study of 34 patients
Regent, A.
Redeker, S.
Deroux, A.
Kieffer, P.
Ly, K.
Dougados, M.
Liozon, E.
Larroche, C.
Guillevin, L.
Bouillet, L.
Espitia, O.
Costeodat-Chalumeau, N.
Soubrier, M.
Brihaye, B.
Liferman, F.
Lefevre, G.
Puechal, X.
Mouthon, L.
Toussirot, E.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 7 - 7
[7] Utility of Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Study of 471 Patients
Benavides Villanueva, Fabricio
Corrales, Cristina
Loricera, Javier
Calderon-Goercke, Monica
Moriano, Clara
Castaneda, Santos
Javier Narvaez, Francisco
Aldasoro, Vicente
Maiz, Olga
Melero, Rafael
Ignacio Villa, Juan
Vela-Casampere, Paloma
Romero Yuste, Susana
Luis Callejas, Jose
De Miguel, Eugenio
Galindez-Agirregoikoa, Eva
Sivera, Francisca
Carlos Fernandez-Lopez, Jesus
Galisteo, Carles
Ferraz Amaro, Ivan
Sanchez Martin, Julio
Sanchez-Bilbao, Lara
Luis Hernandez, Jose
Gonzalez Gay, Miguel Angel
Blanco, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 944 - 946
[8] Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
Loricera, Javier
Blanco, Ricardo
Hernandez, Jose L.
Castaneda, Santos
Mera, Antonio
Perez-Pampin, Eva
Peiro, Enriqueta
Humbria, Alicia
Calvo-Alen, Jaime
Aurrecoechea, Elena
Narvaez, Javier
Sanchez-Andrade, Amalia
Vela, Paloma
Diez, Elvira
Mata, Cristina
Lluch, Pau
Moll, Concepcion
Hernandez, Inigo
Calvo-Rio, Vanesa
Ortiz-Sanjuan, Francisco
Gonzalez-Vela, Carmen
Pina, Trinitario
Gonzalez-Gay, Miguel A.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : 717 - 723
[9] TOCILIZUMAB IN GIANT CELL ARTERITIS: A MULTICENTRE OPEN-LABEL STUDY OF34 PATIENTS
Regent, A.
Redeker, S.
Deroux, A.
Kieffer, P.
Ly, K.
Dougados, M.
Eric, L.
Larroche, C.
Guillevin, L.
Bouillet, L.
Espitia, O.
Costedoat-Chalumeau, N.
Soubrier, M.
Brihaye, B.
Liferman, F.
Lefebvre, G.
Puechal, X.
Mouthon, L.
Toussirot, E.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 794 - 794
[10] Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study
Vitiello, Gianfranco
Battaglini, Carolina Orsi
Carli, Giulia
Radice, Anna
Matucci, Andrea
Vultaggio, Alessandra
Olianti, Catia
Parronchi, Paola
Maggi, Enrico
Cammelli, Daniele
ANGIOLOGY, 2018, 69 (09) : 763 - 769

← 1 2 3 4 5 →